1- (-D-glycopyranosyl) - 3 - (4-cyclopropylphenylmethyl) - 4 - halogeno indole derivatives and use thereof as SGLT inhibitors

Details for Australian Patent Application No. 2007277662 (hide)

Owner Mitsubishi Tanabe Pharma Corporation

Inventors Sakamaki, Shigeki; Nomura, Sumihiro

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007277662

PCT Pub. Number WO2008/013322

Priority 60/886,178 23.01.07 US; 60/820,604 27.07.06 US

Filing date 27 July 2007

Wipo publication date 31 January 2008

Acceptance publication date 3 February 2011

International Classifications

C07H 19/04 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

A61K 31/706 (2006.01)

Event Publications

12 February 2009 PCT application entered the National Phase

  PCT publication WO2008/013322 Priority application(s): WO2008/013322

3 February 2011 Application Accepted

  Published as AU-B-2007277662

2 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007277684-Monoclonal antibody to soluble LOX-1

2007277656-Resin composition, method for producing the same and molded article